Members

VITAMFERO

Immunobiothérapies

Incorporated in late 2005, VitamFero SA is a privately held biotech company whose mission, founded on an innovative and patented technology (i.e. Toxo KO), is to create, develop, register and market novel anti-infectious vaccines, first against Apicomplexe parasites such as:
– Toxoplasma gondii (toxoplasmosis agent)
– Neospora
– Toxoplasma gondii (toxoplasmosis agent)
– Neospora caninum (neosporosis agent)
– Cryptosporidium parvum (cryptosporidiosis agent).
With headquarters in Evry (France) and laboratories in Tours (France), VitamFero is involved first in veterinary healthcare.

Take contact

Type de structure :
Address: 8 rue André Boquel
49100 Angers